- Home
- INDV vs MAC Comparison
INDV vs MAC Comparison
Compare INDV & MAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | MAC |
|---|---|---|
| Founded | 1994 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.8B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | INDV | MAC |
|---|---|---|
| Price | $33.38 | $18.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | ★ $35.75 | $19.24 |
| AVG Volume (30 Days) | ★ 3.1M | 1.6M |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 3.74% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $1,180,000,000.00 | $1,099,978,000.00 |
| Revenue This Year | $1.26 | $11.53 |
| Revenue Next Year | N/A | $0.20 |
| P/E Ratio | $34.65 | ★ N/A |
| Revenue Growth | N/A | ★ 39.55 |
| 52 Week Low | $7.62 | $12.48 |
| 52 Week High | $38.00 | $21.12 |
Technical Indicators
Market Signals| Indicator | INDV | MAC |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 49.88 |
| Support Level | $33.76 | $18.02 |
| Resistance Level | $36.22 | $18.35 |
| Average True Range (ATR) | 1.14 | 0.42 |
| MACD | -0.46 | -0.10 |
| Stochastic Oscillator | 7.10 | 38.30 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About MAC Macerich Company (The)
Macerich invests in premium mall assets. The company owns 29 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with two power centers and seven other real estate assets. The company's total portfolio has 42.2 million square feet of gross leasable area and averaged $849 sales per square foot over the 12 months ended in June 2025.